SEARCH

SEARCH BY CITATION

References

  • 1
    Shapiro AMJ, Lakey JRT, Ryan E et al. Islet transplantation in seven patients with type 1 diabetes mellitus using steroid-free immunosuppression regimen. N Engl J Med 2000; 343: 230238.
  • 2
    Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 20602069.
  • 3
    Molano RD, Berney T, Li H et al. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell co-stimulation. Diabetes 2001; 50: 270276.
  • 4
    Jaeger C, Brendel MD, Eckhard M, Bretzel RG. Islet autoantibodies as potential markers for disease recurrence in clinical islet transplantation. Exp Clin Endocrinol Diabetes 2000; 108: 328333.
  • 5
    Ricordi C, Zeng YJ, Alejandro R et al. In vivo effects of FK506 on human pancreatic islets. Transplantation 1991; 52: 519522.
  • 6
    Paty BW, Harmon JS, Marsh CL, Robertson RP. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 2002; 73: 353357.
  • 7
    Bell E, Cao X, Moibi JA et al. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 2003; 52: 27312739.
  • 8
    Ryan EA, Lakey JRT, Rajotte RV et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710719.
  • 9
    Bottino R, Fernandez LA, Ricordi C et al. Transplantation of allogeneic islets of Langerhans in the rat liver: Effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998; 47: 316323.
  • 10
    Cattan P, Berney T, Schena S et al. Early assessment of apoptosis in isolated islets of Langerhans. Transplantation 2001; 71: 857862.
  • 11
    Li X, Chen H, Epstein PN. Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species. J Biol Chem 2004; 279: 765771.
  • 12
    Bottino R, Balamurugan AN, Tse H et al. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004; 53: 22592268.
  • 13
    Berney T, Molano RD, Cattan P et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001; 71: 125132.
  • 14
    Ritz-Laser B, Oberholzer J, Toso C et al. Molecular detection of circulating β-cells after islet transplantation. Diabetes 2002; 51: 557561.
  • 15
    Lee TC, Barshes NR, Brunicardi FC et al. Procurement of the human pancréas for pancreatic islet isolation. Transplantation 2004; 78: 481483.
  • 16
    Ricordi C, Lacy PE, Finke EH et al. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413420.
  • 17
    Bucher P, Mathe Z, Morel P et al. Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation 2005; 79: 9197.
  • 18
    Berney T, Pileggi A, Molano R, Ricordi C. Pancreatic islet cells. In: AtalaA, LanzaR, eds. Methods of tissue engineering. San Diego : Academic Press, 2001: 203218.
  • 19
    Goss JA, Soltes G, Goodpastor SE et al. Pancreatic islet transplantation: The radiographic approach. Transplantation 2003; 76: 199203.
  • 20
    Berney T, Ricordi C. Islet transplantation: The future? Langenbecks Arch Surg 2000; 385: 373378.
  • 21
    Wang J, Shen L, Najafi H et al. Regulation of insulin preRNA splicing by glucose. Proc Natl Acad Sci U S A 1997; 94: 43604365.
  • 22
    Pileggi A, Ricordi C, Alessiani M, Inverardi L. Factors influencing islet of Langerhans graft function and monitoring. Clin Chim Acta 2001; 310: 316.
  • 23
    Shapiro AMJ, Hao EG, Lakey JRT et al. Novel approaches toward early diagnosis of islet allograft rejection. Transplantation 2001; 71: 17091718.
  • 24
    Olack BJ, Swanson CJ, Flavin KS et al. Sensitization to HLA antigens in islet recipients with failing transplants. Transplant Proc 1997; 29: 22682269.
  • 25
    Bosi E, Braghi S, Maffi P et al. Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 2001; 50: 24642471.
  • 26
    Roep BO, Stobbe I, Duinkerken G et al. Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes 1999; 48: 484490.
  • 27
    Reijonen H, Kwok WW, Nepom GT. Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers. Ann N Y Acad Sci 2003; 1005: 8287.
  • 28
    Mallone R, Nepom GT. MHC class II tetramers and the pursuit of antigen-specific T cells: Define, deviate, delete. Clin Immunol 2003; 110: 232242.
  • 29
    Paty BW, Bonner-Weir S, Laughlin MR, McEwan AJ, Shapiro AM. Toward development of imaging modalities for islets after transplantation: Insights from the National Institutes of Health Workshop on Beta Cell Imaging. Transplantation 2004; 77: 11331137.
  • 30
    Jirak D, Kriz J, Herynek V et al. MRI of transplanted pancreatic islets. Magn Reson Med 2004; 52: 12281233.
  • 31
    Han D, Xu X, Pastori RL, Ricordi C, Kenyon NS. Elevation of cytotoxic lymphocyte gene expression is predictive of islet allograft rejection in nonhuman primates. Diabetes 2002; 51: 562566.
  • 32
    Han D, Xu X, Baidal D et al. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients. Elevation precedes clinical evidence of rejection. Diabetes 2004; 53: 22812290.
  • 33
    Bennet W, Sundberg B, Groth CG et al. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 1999; 48: 19071914.
  • 34
    Davalli AM, Scaglia L, Zangen DH et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45: 11611167.
  • 35
    Menger MD, Yamauchi J, Vollmar B. Revascularization and microcirculation of freely grafted islets of Langerhans. World J Surg 2001; 25: 509515.